Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

7,850 total articles

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

AnaptysBio has completed the spin-off of its biopharma operations into First Tracks Biotherapeutics and will now operate as a royalty management company. The new virtual model focuses on managing financial collaborations related to Jemperli with GSK and imsidolimab with Vanda, aiming for high operational efficiency and returning value to shareholde…

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

Intelligent Bio Solutions Inc. (Nasdaq: INBS) has initiated a validation study to reduce the analysis time of its Intelligent Fingerprinting Drug Screening System from ten minutes to under three minutes. This improvement aims to enhance its competitive position in the growing U.S. roadside drug testing market, projected to reach $1.62 billion by 20…

KUSTOM ENTERTAINMENT, INC. ANNOUNCES PLANNED ADDITION OF FOURTH CONCERT DAY IN THE SECOND QUARTER OF 2026

KUSTOM ENTERTAINMENT, INC. ANNOUNCES PLANNED ADDITION OF FOURTH CONCERT DAY IN THE SECOND QUARTER OF 2026

Kustom Entertainment, a Nasdaq-listed live music event producer, announced it will add a fourth concert day in the second quarter of 2026 to capitalize on increased tourism and regional activity during major global sports events in Kansas City. This expansion aligns with the company's shift to focus solely on entertainment following divestitures of…

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GH Research PLC welcomes the White House Executive Order aimed at speeding up the development and patient access to innovative therapies for serious mental illnesses, including psychedelic treatments. The company is advancing its proprietary inhaled mebufotenin candidate, GH001, toward a global pivotal Phase 3 trial for treatment-resistant depressi…

Wearable Devices Announces Collaboration with Meta-Bounds to Enable Intuitive Neural Control for AR Glasses

Wearable Devices Announces Collaboration with Meta-Bounds to Enable Intuitive Neural Control for AR Glasses

Wearable Devices Ltd. announced a strategic collaboration with Meta-Bounds Inc. to integrate its AI-powered neural wristband technology with Meta-Bounds' augmented reality hardware. The partnership plans to showcase initial demos at the Augmented World Expo 2026 and aims to develop both short-term intuitive spatial interaction tech and long-term en…

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Oragenics, Inc. has initiated dosing of patients in its Phase IIa clinical trial for ONP-002, targeting mild traumatic brain injury (concussion). The trial is underway in Australia, with plans for U.S. trials pending FDA approval. ONP-002 uses a proprietary intranasal delivery system to address neurological injury mechanisms rather than merely symp…

MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition

MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition

MISTRAS Group, Inc., a global leader in industrial asset integrity and testing solutions, has received Frost & Sullivan's 2026 Global NDT Field Inspection Services Company of the Year award. The recognition highlights MISTRAS' integrated approach combining advanced inspection services, engineered products, and proprietary software to deliver action…

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

Scilex Holding Company announced that its board has approved a dividend distribution of Dream Bowl I Meme Coin Tokens to holders of its common stock and other eligible equity securities. Stockholders as of April 30, 2026 will receive five Dream Bowl Tokens per share. The tokens are digital collectibles without equity or monetary rights, intended so…

Viasat Confirms ViaSat-3 F3 Satellite to Launch April 27, 2026

Viasat Confirms ViaSat-3 F3 Satellite to Launch April 27, 2026

Viasat, Inc. announces the confirmed launch date of its ViaSat-3 F3 satellite on April 27, 2026, aboard a SpaceX Falcon Heavy rocket. This satellite will complete the ViaSat-3 constellation, substantially increasing secure, flexible high-capacity bandwidth over the Asia-Pacific region. The launch and deployment will further strengthen Viasat's glob…

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Akari Therapeutics reported positive preclinical results for its lead ADC candidate AKTX-101, which uses a novel RNA spliceosome-targeting payload PH1. The data show superior potency and cancer cell killing compared to existing TROP2 ADCs with Topoisomerase I inhibitor payloads across bladder, lung, and breast cancer models, including drug-resistan…

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

WeRide’s WRD 3.0 autonomous driving solution won first place at the Wuhu round of the Second China Urban Intelligent Driving Competition, marking its fourth consecutive victory. The system demonstrates advanced capabilities in complex urban environments, is in mass production across several vehicle models, and the company plans continued domestic a…

SAIC Awarded New $75.2M PRISM Task Order to Advance the Naval Air Systems Command’s Mission-Critical Aviation Systems

SAIC Awarded New $75.2M PRISM Task Order to Advance the Naval Air Systems Command’s Mission-Critical Aviation Systems

Science Applications International Corp. (SAIC) has been awarded a $75.2 million task order under the GSA PRISM contract to provide engineering and sustainment services to the Naval Air Systems Command. The contract focuses on maintaining and advancing critical aviation systems including AAE and SE sustainment and supports the Navy's MQ-25 Stingray…

Genco Shipping & Trading Limited Announces Further Fleet Renewal and Growth as Part of Comprehensive Value Strategy

Genco Shipping & Trading Limited Announces Further Fleet Renewal and Growth as Part of Comprehensive Value Strategy

Genco Shipping & Trading Limited announced the acquisition of a 2019-built scrubber-fitted Capesize vessel for $65 million and the sale of two older, less fuel-efficient Supramax vessels for a total of $21.2 million. This fleet renewal enhances their premium earning asset base, increases operating leverage, and is expected to improve earnings power…

ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network

ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network

ENvue Medical announced that a 255-bed Virginia nonprofit regional medical center affiliated with the Mayo Clinic Care Network has adopted its ENvue™ Navigation Platform. This marks the company's 40th U.S. hospital customer. The technology enables nursing-led bedside feeding tube placement, increasing efficiency by shifting procedures from interven…

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Turbo Energy announced a strategic partnership with Hithium to integrate its AI-driven energy optimization platform into Hithium's battery storage systems. This collaboration aims to deploy intelligent energy storage solutions for commercial and industrial sectors in Europe and Latin America, enhancing efficiency, operational resilience, and reduci…

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma, a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs), welcomed the White House Executive Order aimed at advancing psychedelic research and regulatory pathways for treating serious mental health disorders. The Executive Order encourages FDA prioritization, expanded patient access, increased funding, and…

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Nano-X Imaging Ltd. announced a strategic commercial agreement with Howard Technology Solutions to market and deploy 300 FDA-cleared Nanox.ARC 3D digital tomosynthesis imaging systems across U.S. healthcare and public sector facilities over the next three years. This partnership leverages Howard's national reach and expertise to expand Nanox's pres…

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Foresight Autonomous Holdings Ltd. has signed a non-binding term sheet with VisionWave Holdings, Inc. for a strategic equity investment of up to $17.5 million, valuing Foresight at approximately $35 million, a threefold premium to its current market value. The investment aims to strengthen Foresight's financial position and accelerate development a…